{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05902988",
            "orgStudyIdInfo": {
                "id": "VLS-1488-2201"
            },
            "organization": {
                "fullName": "Volastra Therapeutics, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer",
            "officialTitle": "A Phase I/II Study of VLS-1488 (an Oral KIF18A Inhibitor) in Subjects With Advanced Cancer",
            "therapeuticArea": [
                "Oncology and Hematology",
                "Other"
            ],
            "study": "a-phase-i-ii-study-of-vls-in-subjects-with-advanced-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-10-18",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-06",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-05-31",
            "studyFirstSubmitQcDate": "2023-06-02",
            "studyFirstPostDateStruct": {
                "date": "2023-06-15",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-15",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-16",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Volastra Therapeutics, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a first-in-human phase I/II study to examine the safety, tolerability and preliminary efficacy of VLS-1488 in subjects with advanced cancers.",
            "detailedDescription": "This a first-in-human phase I/II study designed to assess the safety, tolerability and preliminary efficacy of VLS-1488 monotherapy and consists of two parts: Dose Escalation and Dose Expansion.\n\nDose Escalation will examine the safety and tolerability of VLS-1488 in different solid tumor types at various dose levels through a series of Dose Escalation and Backfill Cohorts to identify the Maximum Tolerated Dose (MTD) and to select dose levels for Dose Expansion. The criteria for dose (de-)escalation will be based on a Bayesian Optimal Interval (BOIN) design.\n\nDose Expansion will examine the safety, tolerability, Drug Drug Interaction (DDI) risk, Food Effect (FE) and preliminary efficacy of VLS-1488 in different tumor types and/or dose levels of interest through various expansion cohorts.\n\nVLS-1488 will be given orally in 28-day cycles. Dosing will be continued until disease progression, unacceptable toxicity, withdrawal of consent, or other stopping criteria are met."
        },
        "conditionsModule": {
            "conditions": [
                "Advanced Solid Tumor",
                "High Grade Serous Adenocarcinoma of Ovary",
                "Squamous Non-small-cell Lung Cancer",
                "Triple Negative Breast Cancer",
                "Gastric Adenocarcinoma",
                "Colorectal Adenocarcinoma",
                "Esophageal Squamous Cell Carcinoma",
                "Esophageal Adenocarcinoma",
                "Gastroesophageal Junction Adenocarcinoma",
                "Transitional Cell Carcinoma of Bladder",
                "Head and Neck Squamous Cell Carcinoma",
                "Ovarian Carcinosarcoma",
                "Uterine Carcinosarcoma",
                "Uterine Serous Carcinoma",
                "Endometrium Cancer",
                "Chromosomal Instability"
            ],
            "keywords": [
                "KIF18A Inhibitor"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 120,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Dose Escalation: Dose Escalation Cohorts",
                    "type": "EXPERIMENTAL",
                    "description": "Subjects will be enrolled at various doses and/or schedules of VLS-1488. These Dose Escalation Cohorts will be utilized to identify the MTD and to select dose levels for Dose Expansion.",
                    "interventionNames": [
                        "Drug: VLS-1488"
                    ]
                },
                {
                    "label": "Dose Escalation: Backfill Cohorts",
                    "type": "EXPERIMENTAL",
                    "description": "Additional subjects may be enrolled at any dose level that does not meet de-escalation or elimination rules per the BOIN design. These Backfill Cohorts will be utilized to build additional data to support selection of doses and/or tumor types for further study in Dose Expansion.",
                    "interventionNames": [
                        "Drug: VLS-1488"
                    ]
                },
                {
                    "label": "Dose Expansion: Exploration Cohorts",
                    "type": "EXPERIMENTAL",
                    "description": "Subjects with a selected single tumor type will be randomized 1:1 into Exploration Cohorts at two or more dose levels of interest. A subset of subjects will have additional assessments to examine the potential for VLS-1488 to interact with other drugs and the effect of food on VLS-1488 absorption.",
                    "interventionNames": [
                        "Drug: VLS-1488"
                    ]
                },
                {
                    "label": "Dose Expansion: Development Cohorts",
                    "type": "EXPERIMENTAL",
                    "description": "Subjects with other tumor types will be enrolled at a single dose level of interest. These Development Cohorts will be utilized to examine the preliminary efficacy of VLS-1488 in various tumor types.",
                    "interventionNames": [
                        "Drug: VLS-1488"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "VLS-1488",
                    "description": "VLS-1488 tablets will be given orally.",
                    "armGroupLabels": [
                        "Dose Escalation: Backfill Cohorts",
                        "Dose Escalation: Dose Escalation Cohorts",
                        "Dose Expansion: Development Cohorts",
                        "Dose Expansion: Exploration Cohorts"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Dose Escalation: Incidence of Dose Limiting Toxicities (DLTs) in DLT-evaluable subjects",
                    "timeFrame": "Up to 12 months"
                },
                {
                    "measure": "Dose Escalation: Determination of the MTD of VLS-1488",
                    "timeFrame": "Up to 12 months"
                },
                {
                    "measure": "Dose Escalation: Frequency of Serious Adverse Events (SAEs) graded according to the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE) version 5.0",
                    "timeFrame": "Up to 12 months"
                },
                {
                    "measure": "Dose Escalation: Frequency of Treatment-related Adverse Events (AEs) graded per NCI-CTCAE version 5.0",
                    "timeFrame": "Up to 12 months"
                },
                {
                    "measure": "Dose Escalation: Frequency of Treatment-Emergent AEs (TEAEs) graded per NCI-CTCAE version 5.0",
                    "timeFrame": "Up to 12 months"
                },
                {
                    "measure": "Dose Escalation: Frequency of Dose Interruptions and Permanent Treatment Discontinuations",
                    "timeFrame": "Up to 12 months"
                },
                {
                    "measure": "Dose Expansion: Frequency of Trigger Events (TEs)",
                    "timeFrame": "Up to 18 months"
                },
                {
                    "measure": "Dose Expansion: Objective Response Rate (ORR) as assessed by Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1",
                    "timeFrame": "Up to 18 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Dose Escalation: ORR as assessed by RECIST version 1.1",
                    "timeFrame": "Up to 12 months"
                },
                {
                    "measure": "Dose Expansion: Frequency of SAEs graded according to NCI-CTCAE version 5.0",
                    "timeFrame": "Up to 18 months"
                },
                {
                    "measure": "Dose Expansion: Frequency of Treatment-related AEs graded according to NCI-CTCAE version 5.0",
                    "timeFrame": "Up to 18 months"
                },
                {
                    "measure": "Dose Expansion: Frequency of TEAEs graded according to NCI-CTCAE version 5.0",
                    "timeFrame": "Up to 18 months"
                },
                {
                    "measure": "Dose Expansion: Frequency of Dose Interruptions and Permanent Treatment Discontinuations",
                    "timeFrame": "Up to 18 months"
                },
                {
                    "measure": "Dose Expansion: Area Under the Plasma Concentration-Time Curve (AUC) of Midazolam and its metabolite 1'-hydroxymidazolam",
                    "timeFrame": "Up to 18 months"
                },
                {
                    "measure": "Dose Expansion: Maximum Plasma Concentration (Cmax) of Midazolam and its metabolite 1'-hydroxymidazolam",
                    "timeFrame": "Up to 18 months"
                },
                {
                    "measure": "Dose Expansion: Evaluation of CA-125 response by Gynecologic Cancer InterGroup (GCIG) criteria (High Grade Serous Ovarian Cancer only)",
                    "timeFrame": "Up to 18 months"
                },
                {
                    "measure": "Dose Escalation & Dose Expansion: Duration of Response (DOR) as assessed by RECIST version 1.1",
                    "timeFrame": "Up to 32 months"
                },
                {
                    "measure": "Dose Escalation & Dose Expansion: Disease Control Rate (DCR) as assessed by RECIST version 1.1",
                    "timeFrame": "Up to 32 months"
                },
                {
                    "measure": "Dose Escalation & Dose Expansion: Progression Free Survival (PFS) as assessed by RECIST version 1.1",
                    "timeFrame": "Up to 32 months"
                },
                {
                    "measure": "Dose Escalation & Dose Expansion: Cmax of VLS-1488",
                    "timeFrame": "Up to 32 months"
                },
                {
                    "measure": "Dose Escalation & Dose Expansion: AUC of VLS-1488",
                    "timeFrame": "Up to 32 months"
                },
                {
                    "measure": "Dose Escalation & Dose Expansion: Trough Concentration (Ctrough) of VLS-1488",
                    "timeFrame": "Up to 32 months"
                },
                {
                    "measure": "Dose Escalation & Dose Expansion: Time to Maximum Plasma Concentration (Tmax) of VLS-1488",
                    "timeFrame": "Up to 32 months"
                },
                {
                    "measure": "Dose Escalation & Dose Expansion: Ratio of Total Cholesterol to 4\u03b2-hydroxycholesterol in plasma",
                    "timeFrame": "Up to 32 months"
                },
                {
                    "measure": "Dose Escalation & Dose Expansion: Increase in the number of Phospho-Histone 3 positive tumor cells",
                    "timeFrame": "Up to 32 months"
                },
                {
                    "measure": "Dose Escalation & Dose Expansion: Frequency of Micronucleated Reticulocytes in blood",
                    "timeFrame": "Up to 32 months"
                },
                {
                    "measure": "Dose Escalation & Dose Expansion: Increase in Micronuclei in Circulating Tumor Cells",
                    "timeFrame": "Up to 32 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\n* All Parts: Age \u2265 18 years, ECOG Performance Status \u2264 1, at least 1 site of measurable disease evaluable by CT scan or MRI per RECIST 1.1, able to take oral medication without alteration\n* Dose Escalation: No available therapeutic options to provide clinically meaningful benefits in the following tumor types: High Grade Serous Ovarian Cancer, Squamous Non -Small Cell Lung Cancer, Triple Negative Breast Cancer, Gastric Adenocarcinoma (not EBV+), Colorectal, Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction, Bladder (transitional cell), Head and Neck Squamous Cell Carcinomas (not nasopharynx, sinonasal or lip), Ovarian Carcinosarcoma, CN-high Endometrial/Uterine\n* Dose Expansion: Must have been previously treated with several lines of standard of care treatment specified in the protocol in the following tumor types: High Grade Serous Ovarian Cancer, Squamous Non-Small Cell Lung Cancer, Triple Negative Breast Cancer, Gastric Adenocarcinoma (not EBV+), Colorectal, Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Head and Neck Squamous Cell Carcinomas (not nasopharynx, sinonasal or lip), CN-high Endometrial/Uterine\n\nKey Exclusion Criteria:\n\n* MSI-H, dMMR, POLE gene hotspot mutated, or known hypermutator phenotype\n* Previously received KIF18A inhibitor\n* Current CNS metastases or leptomeningeal disease\n* Cardiac parameters: MI or stroke \u2264 1 year, unstable angina/PE/DVT/CABG \u2264 6 months, NYHA Class \u2265 II, LVEF \\< 50%\n* Inability to comply with concomitant medication restrictions with respect to strong inhibitors and inducers of CYP3A, and clinical inhibitors of MDR1 (P-gp) and BCRP\n* Any clinically significant ascites or pleural effusions at time of enrollment, or any therapeutic paracentesis or thoracentesis within 28 days of planned first dose of study drug\n* Bowel obstruction or GI perforation within 6 months of planned first dose of study drug",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Volastra Therapeutics, Inc.",
                    "role": "CONTACT",
                    "phone": "(646) 344-1248",
                    "email": "clinicaltrials@volastratx.com"
                }
            ],
            "locations": [
                {
                    "facility": "University of Colorado Cancer Center",
                    "status": "RECRUITING",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80045",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Yasmin Yazdani Farsad",
                            "role": "CONTACT",
                            "phone": "303-724-9403",
                            "email": "YASMIN.YAZDANIFARSAD@CUANSCHUTZ.EDU"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                },
                {
                    "facility": "Yale Cancer Center",
                    "status": "RECRUITING",
                    "city": "New Haven",
                    "state": "Connecticut",
                    "zip": "06511",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ingrid Palma",
                            "role": "CONTACT",
                            "phone": "203-833-1034",
                            "email": "ingrid.palma@yale.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.30815,
                        "lon": -72.92816
                    }
                },
                {
                    "facility": "Community Health Network",
                    "status": "RECRUITING",
                    "city": "Indianapolis",
                    "state": "Indiana",
                    "zip": "46256",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Megan Haas",
                            "role": "CONTACT",
                            "email": "mhaas2@ecommunity.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.76838,
                        "lon": -86.15804
                    }
                },
                {
                    "facility": "Johns Hopkins Sidney Kimmel Comprehensive Cancer Center",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21224",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Matthew Bark",
                            "role": "CONTACT",
                            "phone": "443-927-8743",
                            "email": "Mbark1@jhmi.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                },
                {
                    "facility": "University of Michigan",
                    "status": "RECRUITING",
                    "city": "Ann Arbor",
                    "state": "Michigan",
                    "zip": "48109",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Cancer AnswerLine",
                            "role": "CONTACT",
                            "phone": "800-865-1125",
                            "email": "CancerAnswerLine@med.umich.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.27756,
                        "lon": -83.74088
                    }
                },
                {
                    "facility": "START Midwest",
                    "status": "RECRUITING",
                    "city": "Grand Rapids",
                    "state": "Michigan",
                    "zip": "49546",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Abigail Van Kirk",
                            "role": "CONTACT",
                            "phone": "616-389-1824",
                            "email": "Abigail.vankirk@startmidwest.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.96336,
                        "lon": -85.66809
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Cancer Center",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Claire Friedman, MD",
                            "role": "CONTACT",
                            "phone": "646-888-4593",
                            "email": "friedmac@mskcc.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "The Christ Hospital",
                    "status": "RECRUITING",
                    "city": "Cincinnati",
                    "state": "Ohio",
                    "zip": "45219",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Abby Reed, RN",
                            "role": "CONTACT",
                            "phone": "513-585-1140",
                            "email": "abby.reed@thechristhospital.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.12713,
                        "lon": -84.51435
                    }
                },
                {
                    "facility": "Women & Infants Hospital",
                    "status": "RECRUITING",
                    "city": "Providence",
                    "state": "Rhode Island",
                    "zip": "02905",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Emma Locke",
                            "role": "CONTACT",
                            "phone": "401-430-8181",
                            "email": "oncologyresearch@wihri.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.82399,
                        "lon": -71.41283
                    }
                },
                {
                    "facility": "M.D. Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ecaterina Dumbrava, MD",
                            "role": "CONTACT",
                            "phone": "713-792-3934",
                            "email": "eeileana@mdanderson.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "UNDECIDED"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000002294",
                    "term": "Carcinoma, Squamous Cell"
                },
                {
                    "id": "D000000230",
                    "term": "Adenocarcinoma"
                },
                {
                    "id": "D000064726",
                    "term": "Triple Negative Breast Neoplasms"
                },
                {
                    "id": "D000077195",
                    "term": "Squamous Cell Carcinoma of Head and Neck"
                },
                {
                    "id": "D000077277",
                    "term": "Esophageal Squamous Cell Carcinoma"
                },
                {
                    "id": "D000002295",
                    "term": "Carcinoma, Transitional Cell"
                },
                {
                    "id": "D000018284",
                    "term": "Cystadenocarcinoma, Serous"
                },
                {
                    "id": "D000002296",
                    "term": "Carcinosarcoma"
                },
                {
                    "id": "D000018200",
                    "term": "Mixed Tumor, Mullerian"
                },
                {
                    "id": "D000016889",
                    "term": "Endometrial Neoplasms"
                },
                {
                    "id": "D000001749",
                    "term": "Urinary Bladder Neoplasms"
                },
                {
                    "id": "D000043171",
                    "term": "Chromosomal Instability"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000018307",
                    "term": "Neoplasms, Squamous Cell"
                },
                {
                    "id": "D000001943",
                    "term": "Breast Neoplasms"
                },
                {
                    "id": "D000001941",
                    "term": "Breast Diseases"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                },
                {
                    "id": "D000006258",
                    "term": "Head and Neck Neoplasms"
                },
                {
                    "id": "D000004938",
                    "term": "Esophageal Neoplasms"
                },
                {
                    "id": "D000005770",
                    "term": "Gastrointestinal Neoplasms"
                },
                {
                    "id": "D000004067",
                    "term": "Digestive System Neoplasms"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000004935",
                    "term": "Esophageal Diseases"
                },
                {
                    "id": "D000005767",
                    "term": "Gastrointestinal Diseases"
                },
                {
                    "id": "D000003536",
                    "term": "Cystadenocarcinoma"
                },
                {
                    "id": "D000018297",
                    "term": "Neoplasms, Cystic, Mucinous, and Serous"
                },
                {
                    "id": "D000018193",
                    "term": "Neoplasms, Complex and Mixed"
                },
                {
                    "id": "D000012509",
                    "term": "Sarcoma"
                },
                {
                    "id": "D000018204",
                    "term": "Neoplasms, Connective and Soft Tissue"
                },
                {
                    "id": "D000014594",
                    "term": "Uterine Neoplasms"
                },
                {
                    "id": "D000005833",
                    "term": "Genital Neoplasms, Female"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000014591",
                    "term": "Uterine Diseases"
                },
                {
                    "id": "D000005831",
                    "term": "Genital Diseases, Female"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                },
                {
                    "id": "D000002869",
                    "term": "Chromosome Aberrations"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000042822",
                    "term": "Genomic Instability"
                },
                {
                    "id": "D000014571",
                    "term": "Urologic Neoplasms"
                },
                {
                    "id": "D000001745",
                    "term": "Urinary Bladder Diseases"
                },
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3585",
                    "name": "Adenocarcinoma",
                    "asFound": "Adenocarcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5220",
                    "name": "Breast Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M5546",
                    "name": "Carcinoma, Non-Small-Cell Lung",
                    "relevance": "LOW"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "asFound": "Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5030",
                    "name": "Urinary Bladder Neoplasms",
                    "asFound": "Carcinoma of Bladder",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11172",
                    "name": "Lung Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M5550",
                    "name": "Carcinoma, Squamous Cell",
                    "asFound": "Squamous Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5551",
                    "name": "Carcinoma, Transitional Cell",
                    "asFound": "Transitional Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M25116",
                    "name": "Chromosomal Instability",
                    "asFound": "Chromosomal Instability",
                    "relevance": "HIGH"
                },
                {
                    "id": "M30373",
                    "name": "Triple Negative Breast Neoplasms",
                    "asFound": "Triple Negative Breast Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1733",
                    "name": "Esophageal Squamous Cell Carcinoma",
                    "asFound": "Esophageal Squamous Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20429",
                    "name": "Cystadenocarcinoma, Serous",
                    "asFound": "Serous Adenocarcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5552",
                    "name": "Carcinosarcoma",
                    "asFound": "Carcinosarcoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20346",
                    "name": "Mixed Tumor, Mullerian",
                    "asFound": "Carcinosarcoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1689",
                    "name": "Squamous Cell Carcinoma of Head and Neck",
                    "asFound": "Head and Neck Squamous Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6741",
                    "name": "Cystadenocarcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M11914",
                    "name": "Adenoma, Pleomorphic",
                    "relevance": "LOW"
                },
                {
                    "id": "M19235",
                    "name": "Endometrial Neoplasms",
                    "asFound": "Endometrium Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M20451",
                    "name": "Neoplasms, Squamous Cell",
                    "relevance": "LOW"
                },
                {
                    "id": "M5218",
                    "name": "Breast Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9348",
                    "name": "Head and Neck Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8088",
                    "name": "Esophageal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7256",
                    "name": "Digestive System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8886",
                    "name": "Gastrointestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8085",
                    "name": "Esophageal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M20441",
                    "name": "Neoplasms, Cystic, Mucinous, and Serous",
                    "relevance": "LOW"
                },
                {
                    "id": "M15327",
                    "name": "Sarcoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M20350",
                    "name": "Neoplasms, Connective and Soft Tissue",
                    "relevance": "LOW"
                },
                {
                    "id": "M17342",
                    "name": "Uterine Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8945",
                    "name": "Genital Neoplasms, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M17339",
                    "name": "Uterine Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8943",
                    "name": "Genital Diseases, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M6109",
                    "name": "Chromosome Aberrations",
                    "relevance": "LOW"
                },
                {
                    "id": "M25088",
                    "name": "Genomic Instability",
                    "relevance": "LOW"
                },
                {
                    "id": "M17320",
                    "name": "Urologic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M5026",
                    "name": "Urinary Bladder Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T5693",
                    "name": "Transitional Cell Carcinoma",
                    "asFound": "Transitional Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3586",
                    "name": "Malignant Mixed Mullerian Tumor",
                    "asFound": "Carcinosarcoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4353",
                    "name": "Ovarian Carcinosarcoma",
                    "asFound": "Ovarian Carcinosarcoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T5820",
                    "name": "Uterine Carcinosarcoma",
                    "asFound": "Uterine Carcinosarcoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T200",
                    "name": "Adenocarcinoma of the Appendix",
                    "relevance": "LOW"
                },
                {
                    "id": "T2141",
                    "name": "Esophageal Cancer",
                    "relevance": "LOW"
                },
                {
                    "id": "T5284",
                    "name": "Soft Tissue Sarcoma",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}